EBIT: Income before interest and taxes.
Benitec Biopharma Limited (BNTC) had EBIT of $-17.18M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-16.15M |
|
-- |
|
-- |
|
$17.18M |
|
$-17.18M |
|
$1.03M |
|
$-16.15M |
|
$-16.15M |
|
$-16.15M |
|
$-16.15M |
|
$-16.15M |
|
$-16.15M |
|
|
EBIT |
$-17.18M |
$-17.16M |
|
36.21M |
|
36.21M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$98.52M |
|
$0.13M |
|
$1.07M |
|
$99.59M |
|
$1.80M |
|
$0.49M |
|
$0.49M |
|
$2.30M |
|
$97.30M |
|
$97.30M |
|
$97.30M |
|
26.25M |
|
| Cash Flow Statement Financials | |
$-23.59M |
|
$-0.02M |
|
$70.48M |
|
$50.93M |
|
$97.86M |
|
$46.93M |
|
$17.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
54.67 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.60% |
|
-16.60% |
|
-16.21% |
|
-16.51% |
|
$3.71 |
|
$-0.65 |
|
$-0.65 |
|